Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.059 AUD | -10.61% |
|
-6.35% | +168.18% |
04-30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
04-18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+168.18% | 8.02M | |
+53.54% | 803B | |
-6.63% | 351B | |
+17.83% | 324B | |
+10.58% | 303B | |
+16.23% | 243B | |
+2.17% | 228B | |
+10.23% | 217B | |
+6.83% | 164B | |
-3.54% | 155B |
- Stock Market
- Equities
- NYR Stock
- News Nyrada Inc.
- Nyrada Secures European Patent for Cholesterol Inhibitor Drug; Shares Rally 16%